Kezar Life Sciences (KZR) Accumulated Expenses (2021 - 2025)
Historic Accumulated Expenses for Kezar Life Sciences (KZR) over the last 5 years, with Q3 2025 value amounting to $3.9 million.
- Kezar Life Sciences' Accumulated Expenses fell 5936.47% to $3.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.9 million, marking a year-over-year decrease of 5936.47%. This contributed to the annual value of $7.9 million for FY2024, which is 2243.48% up from last year.
- As of Q3 2025, Kezar Life Sciences' Accumulated Expenses stood at $3.9 million, which was down 5936.47% from $4.1 million recorded in Q2 2025.
- In the past 5 years, Kezar Life Sciences' Accumulated Expenses registered a high of $10.7 million during Q3 2023, and its lowest value of $2.9 million during Q1 2021.
- Its 5-year average for Accumulated Expenses is $6.2 million, with a median of $6.0 million in 2022.
- As far as peak fluctuations go, Kezar Life Sciences' Accumulated Expenses soared by 8215.67% in 2023, and later plummeted by 5936.47% in 2025.
- Quarter analysis of 5 years shows Kezar Life Sciences' Accumulated Expenses stood at $5.0 million in 2021, then increased by 19.42% to $6.0 million in 2022, then rose by 8.87% to $6.5 million in 2023, then grew by 22.43% to $7.9 million in 2024, then tumbled by 50.51% to $3.9 million in 2025.
- Its Accumulated Expenses stands at $3.9 million for Q3 2025, versus $4.1 million for Q2 2025 and $6.1 million for Q1 2025.